Skip to main content
Daesung Microbiological Labs. Co. Ltd logo

Daesung Microbiological Labs. Co. Ltd — Investor Relations & Filings

Ticker · 036480 ISIN · KR7036480002 KO Manufacturing
Open in API
Filings indexed 126 across all filing types
Latest filing 2023-03-24 Board/Management Inform…
Country KR South Korea
Listing KO 036480

About Daesung Microbiological Labs. Co. Ltd

https://eng.dsmbio.co.kr/

Daesung Microbiological Labs. Co., Ltd. is a company specializing in the development, manufacturing, and distribution of animal pharmaceuticals. Established in 1968, it is a leading vaccine manufacturer operating under KVGMP (Korean Veterinary Good Manufacturing Practice) standards. The company's product portfolio includes a comprehensive range of vaccines, antibiotics, parasiticides, and nutritional supplements. These products are designed for the health and well-being of livestock such as swine, bovine, and poultry, as well as for companion animals like canines. Daesung Microbiological Labs is committed to achieving disease-free livestock through continuous research and technological innovation in animal health.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the changes in the board of directors, specifically regarding outside directors, which falls under the category of Board/Management Information.
2023-03-24 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from Daesung Microbiological Labs titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion (unqualified/proper), key financial data (assets, liabilities, revenue, profit), and auditor information. While it contains financial data, it is a specific regulatory disclosure regarding the submission of the audit report to the exchange, rather than the full annual report (10-K) or a standalone audit report document. Given the structure and the nature of the disclosure, it fits the 'Audit Report / Information' (AR) category as it specifically reports the results of the audit process. FY 2022
2023-03-15 Korean
사업보고서 (2022.12)
Annual Report Classification · 1% confidence The document is a 'Business Report' (사업보고서) for the 57th fiscal year (2022), submitted to the Financial Services Commission and the Korea Exchange. It contains comprehensive financial statements, management discussion and analysis, governance details, and operational information. This is the standard Korean regulatory filing equivalent to a 10-K. FY 2022
2023-03-15 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Daesung Microbiological Labs. It contains the agenda for the 57th Annual General Meeting, including reports on financial statements, director appointments, and remuneration limits. It also includes detailed financial statements (balance sheet, income statement, etc.) and management information as part of the meeting materials. This type of document, which provides information to shareholders to request their attendance and votes for an upcoming meeting, is classified as a Proxy Solicitation & Information Statement.
2023-03-07 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company scheduled its AGM on a date that coincides with many other companies' meetings. Since this is a specific regulatory disclosure regarding meeting logistics rather than the meeting materials themselves (AGM-R) or a proxy statement (PSI), it falls under the general regulatory filing category.
2023-03-07 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Daesung Microbiological Labs. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, dividend declarations, and the election of directors. This falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on upcoming meeting agenda items.
2023-02-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.